Perspective on drug delivery in 2050

Affiliations

¹ Purdue University, Departments of Biomedical Engineering and Pharmaceutics, West Lafayette, IN 47907, USA; Akina, Inc., West Lafayette, IN 47906, USA. Electronic address: kpark@purdue.edu.
² Purdue University, Departments of Biomedical Engineering and Pharmaceutics, West Lafayette, IN 47907, USA.
³ Akina, Inc., West Lafayette, IN 47906, USA.

Kinam Park et al. J Control Release. 2022 Apr.

. 2022 Apr:344:157-159.

doi: 10.1016/j.jconrel.2022.02.025. Epub 2022 Feb 21.

¹ Purdue University, Departments of Biomedical Engineering and Pharmaceutics, West Lafayette, IN 47907, USA; Akina, Inc., West Lafayette, IN 47906, USA. Electronic address: kpark@purdue.edu.
² Purdue University, Departments of Biomedical Engineering and Pharmaceutics, West Lafayette, IN 47907, USA.
³ Akina, Inc., West Lafayette, IN 47906, USA.

No abstract available

Figures

1. Robinson JR, Sustained and Controlled Release Drug Delivery Systems, Dekker, New York, NY, 1978, 773 pages.
1. Robinson JR, Lee VHL, Controlled Release Drug Delivery: Fundamentals and Applications. Second Edition, Revised and Expanded, CRC Press, New York, NY, 1987, 716 pages.
1. Park H, Otte A, Park K, Evolution of drug delivery systems: from 1950 to 2020 and beyond, J. Control. Release 342 (2022) 53–65. - PMC - PubMed
1. Bae YH, Park K, Advanced drug delivery 2020 and beyond: perspectives on the future, Adv. Drug Deliv. Rev 158 (2020) 4–16. - PMC - PubMed
1. Catmull E, Wallace A, Creativity, Inc.: Overcoming the Unseen Forces That Stand in the Way of True Inspiration, Random House, 2014, 368 pages.